Life Sciences Biotech Pharma

Subscribe to Life Sciences Biotech Pharma RSS Feed

May Issue of Bio/Pharma Beat Now Available

Our monthly newsletter reports on the patent law developments in biotech, biologics and pharmaceutical cases, legislation and federal agency actions. This month’s issue covers relevant news from April 2020, including: The Federal Circuit potentially extends the potential reach chemical compound structural similarity obviousness law The Federal Circuit holds that a section 156 patent term extension … Continue Reading

COVID-19 Prioritized Examination Pilot Program

On May 8, 2020, the United States Patent and Trademark Office (USPTO) began a Pilot Program to provide prioritized examination of patent applications of a product or process related to COVID-19 diagnosis or treatment. Examples of such patents include: an Investigational New Drug (IND) application, an Investigational Device Exemption (IDE), a New Drug Application (NDA), … Continue Reading

April Issue of Bio/Pharma Beat Now Available!

Our monthly newsletter reports on the patent law developments in biotech, biologics and pharmaceutical cases, legislation and federal agency actions. This month’s issue covers relevant news from March 2020, including: The Federal Circuit reverses two district court decisions holding method of treatment and method of preparing claims patent ineligible The Federal Circuit finds that clearly … Continue Reading

January Issue of Bio Pharma Beat Now Available

Our monthly newsletter reports on the patent law developments in biotech, biologics and pharmaceutical cases, legislation and federal agency actions. This month’s issue covers relevant news from December 2019, including: The Solicitor General, on behalf of the US, asserts that the Supreme Court’s Section 101 precedent creates “substantial uncertainty” requiring clarification The Federal Circuit holds that there … Continue Reading

December Issue of the Bio/Pharma Beat is Now Available!

Our monthly newsletter reports on the patent law developments in biotech, biologics and pharmaceutical cases, legislation and federal agency actions. This month’s issue covers relevant news from November 2019, including: Federal Circuit affirms the Patent Trial and Appeal Board’s (“PTAB”)’s application of the “blocking patent” doctrine as applied to objective indicia of non-obviousness District court … Continue Reading

Bio/Pharma Newsletter

The November issue of Squire Patton Boggs Bio/Pharma Beat is now available. Our monthly newsletter reports on important patent law developments in biotech, biologics and pharmaceutical cases, legislation and federal agency actions. This month’s issue covers relevant news from October 2019, including: The Federal Circuit holds the “hope” that a potentially promising drug will treat a … Continue Reading
LexBlog